Mirae Asset Global Investments »

Revance Therapeutics shares owned by Mirae Asset Global Investments

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Mirae Asset Global Investments from 13F filings

Historical chart of Mirae Asset Global Investments investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Mirae Asset Global Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Mirae Asset Global Investments

Quarter filed Position value Share count Share price at filing
2023-12-31 $334k 38k 8.79
2023-09-30 $435k 38k 11.47
2023-06-30 $955k 38k 25.31
2023-03-31 $1.2M 37k 32.21
2022-12-31 $685k 37k 18.46
2022-09-30 $853k 32k 27.01
2022-06-30 $303k 22k 14.01
2016-12-31 $323k 16k 20.66